Tasaki Y - Search Results

1

Efficacy of tapentadol for first-line opioid-resistant neuropathic pain in Japan.

Sugiyama Y, Kataoka T, Tasaki Y, Kondo Y, Sato N, Naiki T, Sakamoto N, Akechi T, Kimura K. Sugiyama Y, et al. Among authors: tasaki y. Jpn J Clin Oncol. 2018 Apr 1;48(4):362-366. doi: 10.1093/jjco/hyy023. Jpn J Clin Oncol. 2018. PMID: 29506199

2

Syndrome of Inappropriate Secretion of Antidiuretic Hormone Caused by Carboplatin After Switching from Cisplatin in a Metastatic Urethral Cancer Patient.

Sugiyama Y, Naiki T, Kondo M, Iida K, Kondo Y, Tasaki Y, Kataoka T, Hotta A, Yasui T, Kimura K. Sugiyama Y, et al. Among authors: tasaki y. Urol Case Rep. 2017 Mar 1;12:17-19. doi: 10.1016/j.eucr.2017.02.001. eCollection 2017 May. Urol Case Rep. 2017. PMID: 28271051 Free PMC article.

3

Prognostic significance of hyponatremia induced by systemic chemotherapy in a hospital-based propensity score-matched analysis.

Sugiyama Y, Naiki T, Tasaki Y, Kondo Y, Kataoka T, Etani T, Iida K, Nozaki S, Ando R, Osaga S, Yasui T, Kimura K. Sugiyama Y, et al. Among authors: tasaki y. Int J Clin Oncol. 2020 Apr;25(4):541-551. doi: 10.1007/s10147-019-01579-8. Epub 2019 Dec 6. Int J Clin Oncol. 2020. PMID: 31811602

4

Efficacy of a Newly Modified Short Hydration Method for Gemcitabine and Cisplatin Combination Chemotherapy in Patients with Urothelial Carcinoma.

Naiki T, Sugiyama Y, Tasaki Y, Iida K, Etani T, Hamamoto S, Nagai T, Nozaki S, Ando R, Kawai N, Yasui T. Naiki T, et al. Among authors: tasaki y. Oncology. 2020;98(9):612-620. doi: 10.1159/000506992. Epub 2020 Jun 2. Oncology. 2020. PMID: 32485713 Free PMC article.

5

Low Geriatric Nutritional Risk Index as a Poor Prognostic Marker for Second-Line Pembrolizumab Treatment in Patients with Metastatic Urothelial Carcinoma: A Retrospective Multicenter Analysis.

Etani T, Naiki T, Sugiyama Y, Nagai T, Iida K, Noda Y, Shimizu N, Tasaki Y, Mimura Y, Okada T, Banno R, Kubota H, Hamamoto S, Ando R, Kawai N, Yasui T. Etani T, et al. Among authors: tasaki y. Oncology. 2020;98(12):876-883. doi: 10.1159/000508923. Epub 2020 Aug 28. Oncology. 2020. PMID: 32862183

6

Effectiveness of continuous monitoring by activity tracker of patients undergoing chemotherapy for urothelial carcinoma.

Sugiyama Y, Naiki T, Tasaki Y, Kataoka T, Mimura Y, Kondo Y, Etani T, Iida K, Nozaki S, Ando R, Osaga S, Yasui T, Kimura K. Sugiyama Y, et al. Among authors: tasaki y. Cancer Treat Res Commun. 2020;25:100245. doi: 10.1016/j.ctarc.2020.100245. Epub 2020 Nov 21. Cancer Treat Res Commun. 2020. PMID: 33291048 Free article.

7

Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer.

Tasaki Y, Suzuki M, Katsushima K, Shinjo K, Iijima K, Murofushi Y, Naiki-Ito A, Hayashi K, Qiu C, Takahashi A, Tanaka Y, Kawaguchi T, Sugawara M, Kataoka T, Naito M, Miyata K, Kataoka K, Noda T, Gao W, Kataoka H, Takahashi S, Kimura K, Kondo Y. Tasaki Y, et al. Cancer Res. 2021 Apr 1;81(7):1654-1666. doi: 10.1158/0008-5472.CAN-20-3021. Epub 2021 Mar 1. Cancer Res. 2021. PMID: 33648930

8

Modified Glasgow Prognostic Score 2 as a Prognostic Marker in Patients With Metastatic Urothelial Carcinoma.

Nagai T, Naiki T, Isobe T, Sugiyama Y, Etani T, Iida K, Nozaki S, Noda Y, Shimizu N, Tasaki Y, Mimura Y, Banno R, Kubota H, Hamamoto S, Kawai N, Yasui T. Nagai T, et al. Among authors: tasaki y. In Vivo. 2021 Sep-Oct;35(5):2793-2800. doi: 10.21873/invivo.12565. In Vivo. 2021. PMID: 34410970 Free PMC article.

9

A case of metastatic treatment-emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy.

Naiki T, Naiki-Ito A, Kawai T, Komatsu H, Nishikawa R, Gonda M, Aoki M, Sugiyama Y, Tasaki Y, Yasui T. Naiki T, et al. Among authors: tasaki y. IJU Case Rep. 2022 Jun 29;5(6):431-435. doi: 10.1002/iju5.12501. eCollection 2022 Nov. IJU Case Rep. 2022. PMID: 36341200 Free PMC article.

10

GNRI Sustainability during One Cycle of First-Line Chemotherapy as a Prognostic Indicator in Patients with Metastatic Urothelial Carcinoma.

Sugiyama Y, Naiki T, Tasaki Y, Mimura Y, Etani T, Noda Y, Nozaki S, Shimizu N, Banno R, Nagai T, Isobe T, Ando R, Moritoki Y, Kataoka T, Odagiri K, Aoki M, Gonda M, Yasui T, Hibi Y. Sugiyama Y, et al. Among authors: tasaki y. Oncology. 2023;101(4):224-233. doi: 10.1159/000529203. Epub 2023 Jan 23. Oncology. 2023. PMID: 36689919

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters